latest blog entries
Loading...
Branding...
latest headlines for company on cafepharma
Fierce Biotech
Thu, 10/11/12 - 10:39 am
tags: AbbVie, Actelion, Algeta, Alpharadin, Anacetrapib, Bardoxolone, Bayer, BG-12, Biogen Idec, Bristol-Myers Squibb, darapladib, Eliquis, gantenerumab, Gilead, GS-7977, GSK, Immunogen, Lundbeck, macitentan, Merck, MorphoSys, Novartis, Odanacatib, Pfizer, QVA149, Reata, Regeneron, REGN727, Roche, Sanofi, T-DM1, Takeda, tofacitinib, Vectura, vortioxetine
TheStreet.com
Mon, 09/26/11 - 11:39 am
tags: Algeta, Alpharadin, Amgen, Bayer, Exelixis, prostate cancer, Xgeva
eurekalert.org
Sat, 09/24/11 - 1:26 pm
tags: Algeta, Alpharadin, Bayer, Bone metastases, prostate cancer
Last 30 twitter posts
-
Ikke frykt Bernanke i kveld + Cermaq, RCL, Algeta og Norwegian. t.co/mHnU1fxUBb
-
Algeta ASA - Disclosure of substantial shareholding in Algeta ASA t.co/HrpdRfyaWg
-
Risknivå 4,4% for Mai. Shortlist for mulige innganger er short ITX og YAR,Long Algeta,BRG,GOOG,MSFT og UUP.
-
Algeta ASA - Algeta was founded in 1997 as Anticancer Therapeutic Inventions based upon a unique combination of ra... t.co/yl7lP2zC3Y
-
RT @rondido1: t.co/B6lUgm4H4N..
-
Edison Investment Algeta Investment summary FDA go for Xofigo t.co/xUOzomZtYS
-
Edison Investment Algeta Investment summary FDA go for Xofigo t.co/Xt3De7Edfj
-
Edison Investment Algeta Investment summary FDA go for Xofigo t.co/h8huIrOS7T
-
RT @cheatfamily: t.co/6MzVioPjW9..
-
Healthcare news roundup: Algeta wins approval for new prostate cancer drug t.co/RR9WimjePU
-
Bayer, Algeta win FDA approval for prostate cancer... t.co/lLTjAs4C3R #HEALTH
-
@chasingthealpha @adamfeuerstein NCI+Algeta doing oncology studies for epratuzumab. Algeta using own payload $IMMU t.co/Wtcj6MU6CJ
-
Bayer and Algeta's Xofigo has centralised distribution with Cardinal Health, production issues resolved [BioPharm Insight]
-
Edison Research: Algeta - FDA go for Xofigo - t.co/pDx3IZMFGt
-
#Algeta $ALGETA FDA go for Xofigo - #Edison #Pharma #Healthcare t.co/1tZU5l5ffz
-
RT @BioPharmInsight: FDA approves Algeta/Bayer #Xofigo 3 mo's ahead of sched. Shares up 17%. #hearditherefirst 2011 read coverage t.co/BlJPpQLpER
-
Opening A Window: Algeta Must Find _Xofigo_’s Place In The Prostate Cancer Market t.co/LQVW8rMDCn
-
Opening A Window: Algeta Must Find Xofigo’s Place In The Prostate Cancer Market t.co/F8rup6FPDy
-
UPDATED: FDA OKs pinpoint prostate cancer radiation drug Xofigo from Bayer, Algeta - FierceBiotech: t.co/NrQzcaj1gb
-
Bayer, Algeta win FDA approval for prostate cancer drug t.co/Tdysag1B0x
-
Xofigo approved for castration-resistant prostate cancer t.co/1tVuxYY7nH
-
Algeta - Kronjuvelen av Biotek case - t.co/FMBHqnttjE
-
FDA OKs pinpoint prostate cancer radiation drug Xofigo from Bayer, Algeta - FierceBiotech t.co/sQU4D9fxWX
-
RT @BiotechWorld: FDA OKs pinpoint prostate cancer radiation drug Xofigo from Bayer, Algeta: The approval comes just three month... t.co/VltUwYrgWY
-
United States FDA Approves Algeta ASA's Xofigo t.co/8ZzBlc7y4t
-
Algeta R' (:
-
Algeta wins FDA approval to market new prostate cancer treatment in the United ... Boston Globe t.co/KRihftMUOQ
-
Algeta wins FDA approval for new treatment of prostate cancer Boston Globe t.co/KRihftMUOQ
-
Algeta Rises to Record After Prostate Cancer Medicine Approval Bloomberg t.co/2m1vvgrPKG
-
Algeta Surges to Record After Prostate Cancer Drug Approval Bloomberg t.co/2m1vvgrPKG
Latest Health Message Board Posts
... less well known right now compared to MDV3100 so, if you want to see a really good video about how Alpharadin works go to www.algeta.no/dynside.asp?m=34568&s=34659 , scroll down and click on the “see video on ALSYMPCA clinical trial for bone metastases ...
Posted by:
Drums
at
2013-05-16 12:32:00
on
healingwell.com
... next few months!!! Alpahardin an I.V. radiopharmaceutical video info, the video is before the phase III trial results (fyi).: www.algeta.no/dynside.asp?m=34568&s=34659 (scroll down and click on 'see video on ALSYMPCA clinical trial for bone mets in CRPC ...
Posted by:
robertC
at
2012-12-14 13:58:00
on
healingwell.com
... the hope is that this drug will be available to patients in 2012. Ra-223 is being developed by Algeta ASA and Bayer Healthcare. The study was funded by Algeta ASA. In a second trial, another experimental medicine, called MDV3100, appeared to boost survival ...
Posted by:
zufus
at
2012-03-16 23:13:00
on
healingwell.com
... a survival benefit as the basis for approval. Still experimental prostate cancer drugs from Medivation(MDVN_) and Algeta both employed overall survival in their respective phase III studies. Exelixis believes demonstrating cabozantinib's ability to shrink ...
Posted by:
zufus
at
2012-03-16 20:27:00
on
healingwell.com
... $25,000 for a typical course of treatment with the drug, Alpharadin. But with the rival drug Jevtana costing about $50,000, Algeta and its partner, Bayer, are considering a higher price." So this huge drug company figured in a nice profit for a drug many ...
Posted by:
robertC
at
2012-02-01 13:31:00
on
healingwell.com
... spike on promising prostate cancer drug data By john Created Jun 6 2011 - 10:08am Shares of Norway's Algeta spiked 36 percent this morning after the biotech's partner Bayer unveiled promising data on their castration-resistant prostate cancer treatment ...
Posted by:
Jerry L.
at
2011-10-31 21:38:00
on
healingwell.com
... video which explains the trial and drug mechanism. It is at Tulane Hospital and nowhere else in the US at this time. There is a placebo arm. http://algeta.no/video/algeta_film.html?menuid=11096&smenuid=12312&ssmenuid=
Posted by:
BobCape
at
2011-06-30 10:08:00
on
healingwell.com
Oslo, Norway, 14 December 2012 - Algeta ASA (OSE: ALGETA) announces that Bayer has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for radium-223 dichloride (radium- ...
Posted by:
robertC
at
2011-06-06 16:48:00
on
healingwell.com
... or reoccurred. According to the Boston Globe (5/16, Weisman), Bayer AG licensed Xofigo from the Oslo, Norway-based drug manufacturer, Algeta ASA. The two companies will co-market the treatment to "US urologists and oncologists, " but Bayer, which filed the ...
Posted by:
tarhoosier
at
2010-03-10 19:10:00
on
healingwell.com